Start: August 12, 2021
End: July 2023
This study will evaluate the effects of a program that combines the use of bright light therapy with cognitive behavioral therapy for insomnia on sleep quality and cognitive function in people with mild cognitive impairment or early-stage Alzheimer's disease. Participants will be randomly assigned to either the study sleep program or placebo therapy sessions. All participants will wear a watch-like device that records information on sleep and activity for up to one year. Researchers will also measure changes in memory and cognitive function throughout the study.
Minimum Age: 65 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
San Francisco, CA 94121
RecruitingBernard Landavazo, MA
Lead: University of California, San Francisco
Source: ClinicalTrials.gov ID: NCT03256539